Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Functional and cellular benefits of aerobic exercise in myotonic dystrophy type 1 patients
FY 2018-19
Summary
Myotonic dystrophy type 1 (DM1) is the most common adult-onset muscular dystrophy and second most common muscular dystrophy. DM1 is an autosomal dominant neuromuscular disease that is caused by a trinucleotide repeat mutation in the 3' untranslated region of the Dystrophia myotonica protein kinase (DMPK) gene. This results in a multisystemic disease that is primarily characterized by skeletal muscle wasting, weakness and myotonia. Disease manifestation begins when 50+ CTG repeats are transcribed to form nuclear foci resulting in a toxic gain of function such as sequestration of important RNA-binding proteins leading to defects in RNA metabolism. Studies in murine models of DM1 have shown that exercise training can induce beneficial molecular and physiological effects that ameliorate the disease pathology. Studies in DM1 patients have demonstrated that exercise training increased exercise capacity; however, it is unclear if there were molecular and/or clinically meaningful benefits. This is due to limitations in the previous studies that lacked direct histological, electrophysiologic and molecular outcomes. Thus, the purpose of this study is to examine the functional and cellular benefits of 12-weeks of moderate intensity endurance exercise training in DM1 patients. This study aims to test the hypothesis that aerobic exercise training will induce functional and molecular benefits in DM1 patients, deeming it an easy lifestyle intervention that mitigates the DM1 pathology. Furthermore, through understanding exercise-induced cellular adaptation, it could provide information for future discovery of pharmaceutical, nutritional or exercise interventions. This is the first study to comprehensively understand both the functional and cellular effects of exercise in DM1 patients.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
406279
Name
Mikhail Andrew
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Functional and cellular benefits of aerobic exercise in myotonic dystrophy type 1 patients
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aerobic Exercise; Alternative Splicing; Ctg Repeats; Functional Benefits; Mitochondrial Function; Molecular Benefits; Myotonic Dystrophy Type I; Neuromuscular Physiology; Quality Of Life; Skeletal Muscle
Abstract
Myotonic dystrophy type 1 (DM1) is the most common adult-onset muscular dystrophy and second most common muscular dystrophy. DM1 is an autosomal dominant neuromuscular disease that is caused by a trinucleotide repeat mutation in the 3' untranslated region of the Dystrophia myotonica protein kinase (DMPK) gene. This results in a multisystemic disease that is primarily characterized by skeletal muscle wasting, weakness and myotonia. Disease manifestation begins when 50+ CTG repeats are transcribed to form nuclear foci resulting in a toxic gain of function such as sequestration of important RNA-binding proteins leading to defects in RNA metabolism. Studies in murine models of DM1 have shown that exercise training can induce beneficial molecular and physiological effects that ameliorate the disease pathology. Studies in DM1 patients have demonstrated that exercise training increased exercise capacity; however, it is unclear if there were molecular and/or clinically meaningful benefits. This is due to limitations in the previous studies that lacked direct histological, electrophysiologic and molecular outcomes. Thus, the purpose of this study is to examine the functional and cellular benefits of 12-weeks of moderate intensity endurance exercise training in DM1 patients. This study aims to test the hypothesis that aerobic exercise training will induce functional and molecular benefits in DM1 patients, deeming it an easy lifestyle intervention that mitigates the DM1 pathology. Furthermore, through understanding exercise-induced cellular adaptation, it could provide information for future discovery of pharmaceutical, nutritional or exercise interventions. This is the first study to comprehensively understand both the functional and cellular effects of exercise in DM1 patients.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mikhail, Andrew
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~